We are live on
!
Find out more
Corvus Pharmaceuticals
CRVS
CRVS
50 hedge funds and large institutions have $63.2M invested in Corvus Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 17 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
8.56% more ownership
Funds ownership: 53.24% → 61.8% (+8.6%)
2% more funds holding
Funds holding: 49 → 50 (+1)
1% more capital invested
Capital invested by funds: $62.8M → $63.2M (+$396K)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
24% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 17
60% less call options, than puts
Call options by funds: $104K | Put options by funds: $261K
Holders
50
Holders Change
+1
Holders Change %
+2.04%
% of All Funds
0.87%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
13
Reduced
17
Closed
3
Calls
$104K
Puts
$261K
Net Calls
-$157K
Net Calls Change
+$212K
Top Buyers
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
+$9.85M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
+$1.24M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$300K |
| 4 |
BlackRock
New York
|
+$147K |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
+$115K |
